Dexcom G7 Lawsuit, Class Action Over Failed Alerts and FDA Recalls Rocks Diabetes Device Market
The Dexcom G7 lawsuit centers on allegations that Dexcom marketed its flagship glucose monitor as “the most accurate” CGM despite defective alert systems and sensors that failed before their advertised 10-day wear period. Filed in October 2025 in the U.S. District Court for the Central District of California (Case No. 8:25-cv-02333), the class action follows…









